Article
Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients
5 Sept 2012
Abstract excerpt
BACKGROUND: The clinical course of cutaneous melanoma (CM) can differ significantly for patients with identical stages of disease, defined clinico-pathologically, and no molecular markers differentiate patients with such a diverse prognosis. This study aimed to define the prognostic value of whole genome DNA methylation profiles in stage III CM. METHODS: Genome-wide methylation profiles were evaluated by the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
